AMEX:BDR

Stock Analysis Report

Blonder Tongue Laboratories

Executive Summary

Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television signal encoding, transcoding, digital transport, and broadband product solutions in the United States.

Snowflake

Fundamentals

Adequate balance sheet and fair value.


Similar Companies

Share Price & News

How has Blonder Tongue Laboratories's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

5.5%

BDR

1.1%

US Communications

0.4%

US Market


1 Year Return

-31.4%

BDR

4.6%

US Communications

11.4%

US Market

Return vs Industry: BDR underperformed the US Communications industry which returned 3.2% over the past year.

Return vs Market: BDR underperformed the US Market which returned 8.9% over the past year.


Shareholder returns

BDRIndustryMarket
7 Day5.5%1.1%0.4%
30 Day1.4%-2.9%0.3%
90 Day-25.5%-14.1%-1.2%
1 Year-31.4%-31.4%7.0%4.6%13.9%11.4%
3 Year25.0%25.0%52.6%42.7%47.2%37.6%
5 Year-35.2%-35.2%92.2%71.3%62.4%44.6%

Price Volatility Vs. Market

How volatile is Blonder Tongue Laboratories's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Blonder Tongue Laboratories undervalued compared to its fair value and its price relative to the market?

1.88x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate BDR's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate BDR's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: BDR is good value based on its PE Ratio (1.9x) compared to the Communications industry average (29.6x).

PE vs Market: BDR is good value based on its PE Ratio (1.9x) compared to the US market (17.8x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BDR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BDR is good value based on its PB Ratio (0.6x) compared to the US Communications industry average (1.8x).


Next Steps

Future Growth

How is Blonder Tongue Laboratories forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.8%

Forecasted Tech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Blonder Tongue Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Blonder Tongue Laboratories performed over the past 5 years?

44.3%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: BDR has become profitable over the past 5 years, growing earnings by 44.3% per year.

Accelerating Growth: BDR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: BDR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Communications industry (23.8%).


Return on Equity

High ROE: BDR's Return on Equity (28.8%) is considered high.


Return on Assets

ROA vs Industry: BDR has a higher Return on Assets than the Communications industry average last year.


Return on Capital Employed

ROCE Improving: BDR is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Blonder Tongue Laboratories's financial position?


Financial Position Analysis

Short Term Liabilities: BDR's short term assets ($12.3M) exceeds its short term liabilities ($3.7M)

Long Term Liabilities: BDR's short term assets (12.3M) exceeds its long term liabilities (3.0M)


Debt to Equity History and Analysis

Debt Level: BDR's debt to equity ratio (0.4%) is considered satisfactory

Reducing Debt: BDR's debt to equity ratio has reduced from 40.6% to 0.4% over the past 5 years.

Debt Coverage: BDR's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if BDR's interest payments on its debt are well covered by EBIT.


Balance Sheet

Inventory Level: BDR has a high level of physical assets or inventory.

Debt Coverage by Assets: BDR's debt is covered by short term assets (assets are 250.9x debt).


Next Steps

Dividend

What is Blonder Tongue Laboratories's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage2.9%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate BDR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate BDR's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if BDR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BDR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BDR's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Blonder Tongue Laboratories's salary, the management and board of directors tenure and is there insider trading?

4.4yrs

Average management tenure


CEO

Bob Pallé (73yo)

4.4yrs

Tenure

US$170,090

Compensation

Mr. Robert J. Pallé, Jr., also known as Bob, has been Chief Executive Officer of Blonder Tongue Laboratories Inc since May 19, 2015. Mr. Pallé served as President at Blonder Tongue Laboratories, Inc. since ...


CEO Compensation Analysis

Compensation vs. Market: Bob's total compensation ($USD170.09K) is about average for companies of similar size in the US market ($USD509.30K).

Compensation vs Earnings: Bob's compensation has been consistent with company performance over the past year.


Management Age and Tenure

4.4yrs

Average Tenure

54yo

Average Age

Experienced Management: BDR's management team is considered experienced (4.4 years average tenure).


Board Age and Tenure

9.9yrs

Average Tenure

67yo

Average Age

Experienced Board: BDR's board of directors are considered experienced (9.9 years average tenure).


Insider Trading

Insider Buying: BDR insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellUS$2,44919 Sep 19
Eric Skolnik
EntityIndividual
Role
Chief Financial Officer
Senior VP
Shares3,449
Max PriceUS$0.71
SellUS$80018 Sep 19
Eric Skolnik
EntityIndividual
Role
Chief Financial Officer
Senior VP
Shares1,127
Max PriceUS$0.71
SellUS$9,12816 Sep 19
Eric Skolnik
EntityIndividual
Role
Chief Financial Officer
Senior VP
Shares13,424
Max PriceUS$0.68
SellUS$5,02619 Jun 19
James Williams
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares5,127
Max PriceUS$0.99
SellUS$10,41112 Jun 19
James Williams
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares10,000
Max PriceUS$1.05
BuyUS$4,80131 May 19
Ronald Alterio
EntityIndividual
Role
Chief Technology Officer
VP of Engineering & CTO
Shares5,000
Max PriceUS$0.96
SellUS$4,85029 May 19
James Williams
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares5,000
Max PriceUS$0.97
SellUS$4,75028 May 19
James Williams
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares5,000
Max PriceUS$0.95
SellUS$4,81021 May 19
James Williams
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares5,000
Max PriceUS$0.96
SellUS$4,60021 May 19
James Williams
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares5,000
Max PriceUS$0.92
BuyUS$76420 Dec 18
Edward Grauch
EntityIndividual
Role
President
President & COO
Shares637
Max PriceUS$1.20
BuyUS$11,48419 Dec 18
Edward Grauch
EntityIndividual
Role
President
President & COO
Shares9,261
Max PriceUS$1.24
SellUS$7,55319 Dec 18
Jeffrey Smith
EntityIndividual
Role
Head of Sales
Vice President of Sales
Shares6,649
Max PriceUS$1.14
BuyUS$10,47718 Dec 18
Ronald Alterio
EntityIndividual
Role
Chief Technology Officer
VP of Engineering & CTO
Shares8,387
Max PriceUS$1.25
BuyUS$18,16514 Dec 18
Edward Grauch
EntityIndividual
Role
President
President & COO
Shares15,100
Max PriceUS$1.20
BuyUS$1,73612 Dec 18
Edward Grauch
EntityIndividual
Role
President
President & COO
Shares1,527
Max PriceUS$1.14
BuyUS$1,08411 Dec 18
Edward Grauch
EntityIndividual
Role
President
President & COO
Shares943
Max PriceUS$1.15
BuyUS$2,88411 Dec 18
Edward Grauch
EntityIndividual
Role
President
President & COO
Shares2,508
Max PriceUS$1.15
SellUS$35,01606 Dec 18
Jeffrey Smith
EntityIndividual
Role
Head of Sales
Vice President of Sales
Shares31,666
Max PriceUS$1.11
BuyUS$23,06806 Dec 18
Edward Grauch
EntityIndividual
Role
President
President & COO
Shares20,239
Max PriceUS$1.14
BuyUS$12,40030 Nov 18
Gary Scharmett
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares10,000
Max PriceUS$1.24
BuyUS$2,35230 Nov 18
Gary Scharmett
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares2,010
Max PriceUS$1.17
BuyUS$34,58430 Nov 18
Steven Shea
EntityIndividual
Role
Chairman of the Board
Independent Chairman
Shares30,000
Max PriceUS$1.15
BuyUS$2,43930 Nov 18
Edward Grauch
EntityIndividual
Role
President
President & COO
Shares2,217
Max PriceUS$1.10
BuyUS$30,09328 Nov 18
Edward Grauch
EntityIndividual
Role
President
President & COO
Shares27,568
Max PriceUS$1.09

Ownership Breakdown


Management Team

  • Bob Pallé (73yo)

    CEO & Director

    • Tenure: 4.4yrs
    • Compensation: US$170.09k
  • Eric Skolnik (54yo)

    Senior VP

    • Tenure: 18.4yrs
    • Compensation: US$228.36k
  • Ted Grauch (53yo)

    President & COO

    • Tenure: 0.3yrs
  • Jeff Smith (55yo)

    Vice President of Sales

    • Tenure: 8.4yrs
    • Compensation: US$251.05k
  • Ron Alterio (49yo)

    VP of Engineering & CTO

    • Tenure: 1.3yrs

Board Members

  • Anthony Bruno (78yo)

    Independent Director

    • Tenure: 11.7yrs
    • Compensation: US$60.32k
  • Bob Pallé (73yo)

    CEO & Director

    • Tenure: 4.4yrs
    • Compensation: US$170.09k
  • Gary Scharmett (63yo)

    Independent Director

    • Tenure: 21.8yrs
    • Compensation: US$56.15k
  • James Williams (61yo)

    Independent Director

    • Tenure: 26.1yrs
    • Compensation: US$54.75k
  • James Williams (87yo)

    Independent Director

    • Tenure: 4.7yrs
    • Compensation: US$51.55k
  • Steve Necessary (62yo)

    Independent Director

    • Tenure: 1.8yrs
    • Compensation: US$54.84k
  • Steve Shea (60yo)

    Independent Chairman

    • Tenure: 4.4yrs
    • Compensation: US$84.85k
  • Charles Dietz (71yo)

    Independent Director

    • Tenure: 8.1yrs
    • Compensation: US$59.15k

Company Information

Blonder Tongue Laboratories, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Blonder Tongue Laboratories, Inc.
  • Ticker: BDR
  • Exchange: AMEX
  • Founded: 1950
  • Industry: Communications Equipment
  • Sector: Tech
  • Market Cap: US$6.735m
  • Shares outstanding: 9.62m
  • Website: https://www.blondertongue.com

Number of Employees


Location

  • Blonder Tongue Laboratories, Inc.
  • One Jake Brown Road
  • Old Bridge
  • New Jersey
  • 8857
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BDRAMEX (NYSE MKT LLC)YesCommon StockUSUSDDec 1995

Biography

Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television signal encoding, transcoding, digital transport, and broadband product solutions in the United Sta ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/23 23:32
End of Day Share Price2019/10/23 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.